The DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
The multifaceted role of reactive oxygen species in tumorigenesis
Open accessAbstract
Redox homeostasis is an essential requirement of the biological systems for performing various normal cellular functions including cellular growth, differentiation, senescence, survival and aging in humans. The changes in the basal levels of reactive oxygen species (ROS) are detrimental to cells and often lead to several disease conditions including cardiovascular, neurological, diabetes and cancer. During the last two decades, substantial research has been done which clearly suggests that ROS are essential for the initiation, progression, angiogenesis as well as metastasis of cancer in several ways. During the last two decades, the potential of dysregulated ROS to enhance tumor formation through the activation of various oncogenic signaling pathways, DNA mutations, immune escape, tumor microenvironment, metastasis, angiogenesis and extension of telomere has been discovered. At present, surgery followed by chemotherapy and/or radiotherapy is the major therapeutic modality for treating patients with either early or advanced stages of cancer. However, the majority of patients relapse or did not respond to initial treatment. One of the reasons for recurrence/relapse is the altered levels of ROS in tumor cells as well as in cancer-initiating stem cells. One of the critical issues is targeting the intracellular/extracellular ROS for significant antitumor response and relapse-free survival. Indeed, a large number of FDA-approved anticancer drugs are efficient to eliminate cancer cells and drug resistance by increasing ROS production. Thus, the modulation of oxidative stress response might represent a potential approach to eradicate cancer in combination with FDA-approved chemotherapies, radiotherapies as well as immunotherapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ROS play an essential role in carcinogenesis, affecting multiple biological processes, including genomic instability, cell growth, angiogenesis, inflammation, metabolic reprogramming, metastatization, and resistance to apoptosis [77].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [77]
In the citing paper
“Elevated levels of intracellular ROS are known to be one of the reasons for genomic instability and, hence, carcinogenesis [29].”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [29]
In the citing paper
“ROS are known to play a multifaced, opposing role in cancer, by favoring cancer onset at low doses on the one hand, and killing tumors at high doses on the other hand [29,55].”
From 20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells (2023) · cites this paper as [29]
Citations
Cites
2 retracted
Garg, M., Kanojia, D., Mayakonda, A., Ganesan, T. S., Sadhanandhan, B., Suresh, S., Sneha, S., Nagare, R. P., SAID, J. W., Doan, N., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10325-x · Cited by 48
Self-citationRetractedKanojia, D., Garg, M., Martinez, J., Anand, M. T., Luty, S. B., Doan, N., SAID, J. W., Forscher, C. A., Tyner, J. W., & Koeffler, H. P. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0540-x · Cited by 30
Self-citationRetractedBray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
Cited by
Sorted by citations
Items 301–400 of 452
Liao, R.-G., Wang, J., Zhang, F., Fang, Y., Zhou, L., & Zhang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-85537-7 · Cited by 5
Xu, H., Zhang, X., Kang, L., Feng, S., Li, Y., & Zhao, G. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140143 · Cited by 5
Zingiberaceae wonders: the antioxidant powerhouse for optimal health
Boyina, H. K., Chakraborty, S., Atrooz, O. M., Adamska, O., Sanka, K., Atanasov, A. G., Stolarczyk, A., Chellammal, H. S. J., Arora, V., Gangarapu, K., et al. (2025) · Animal Science Papers and Reports · doi:10.2478/aspr-2025-0001 · Cited by 7
Li, H.-L., Wang, J., Dai, H.-W., Liu, J.-J., Liu, Z., Zou, M., Zhang, L., & Wang, W. (2023) · Chinese Medical Sciences Journal · doi:10.24920/004222 · Cited by 5
Huang, D., Yao, Y., Lou, Y., Kou, L., Yao, Q., & Chen, R. (2024) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2024.100307 · Cited by 7
Hsa_circ_0002301 inhibits ferroptosis in gastric cancer by encoding the de novo protein HECTD1-463aa
Wang, S., Wu, C., Wang, J., Feng, Y., Hou, Y., Cao, T., Xu, L., Qian, L., Xia, Y., Xu, L., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06226-7 · Cited by 5
“Owing to their physiological differences in iron and lipid metabolism, along with the abnormal production of reactive oxygen species (ROS) [8, 9], cancer cells may be more susceptible to the regulation of ferroptosis than normal cells [10, 11].”
Nitrogen- and Sulfur-Containing Heterocycles as Dual Anti-oxidant and Anti-cancer Agents
Carradori, S., Guglielmi, P., Luisi, G., & Secci, D. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_180 · Cited by 5
Carpena, M., Garcia‐Oliveira, P., Pereira, A. G., Soria-López, A., Chamorro, F., Collazo, N., Jarboui, A., Simal‐Gándara, J., & Prieto, M. A. (2022) · Reference series in phytochemistry · doi:10.1007/978-3-030-78160-6_35 · Cited by 7
Wang, M., Shen, Y., Hu, X., Zhu, Y., & Wang, J. (2022) · Microchimica Acta · doi:10.1007/s00604-022-05451-x · Cited by 5
“The detection of ROS production stimulated by drugs can be used to clarify the mechanism of anticancer drugs in the treatment of cancer [31].”
BackgroundAdvances in lignin and lignin-based composites in biomedical applications
Taib, M. N. A. M., Osman, S., Solihat, N. N., Arnata, I. W., Sartika, D., Jamal, T., & Saji, V. S. (2026) · Biomaterials Science · doi:10.1039/d5bm01439e · Cited by 4
Tao, M., Fang, X., Liang, Z., Zhang, Z., Gong, W.-H., Tan, X., & Zeng, P. (2026) · Discover Nano · doi:10.1186/s11671-026-04576-9 · Cited by 7
Nootkatone inhibits the progression of glioblastoma by activating the ATF4-CHOP-CHAC1 pathway
Wang, Q., Xue, X., Chen, Z., Zhang, W., Qian, Y., Chen, D., Lin, L., Yuan, Y., Zhao, W., Huang, Z., et al. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01064-1 · Cited by 4
“ROS-induced cell death is considered a promising anti-tumor method recently (Wang et al. 2022a, b; Kirtonia et al. 2020).”
Xu, Z., Chen, X., Zhou, H., Sun, L., Bai, R., Yu, W., Yang, J., & Liu, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1355559 · Cited by 4
“ROS plays a signi fi cant role in the occurrence and development of tumors (35), and the balance between ROS accumulation and antioxidant systems is involved in the cell cycle process.”
BackgroundNDMA enhances claudin-1 and -6 expression viaCYP2E1/ROS in AGS cells
García-García, C. A., Cruz‐Gregorio, A., Pedraza‐Chaverrí, J., Montaño, L. F., & Rendon‐Huerta, E. P. (2024) · Toxicology in Vitro · doi:10.1016/j.tiv.2024.105952 · Cited by 4
Core-shell SERS nanoprobes for ROS detection and imaging during apoptosis
Wang, L., Gao, X., Han, J., Yuan, J., Wang, Z., & Ma, X. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.106339 · Cited by 4
Raj, H., Sharma, S., Tripathi, A., Huddar, V. G., & Jha, S. K. (2025) · Ayush journal of integrative oncology. · doi:10.4103/ajio.ajio_40_25 · Cited by 4
Mohamed, R., Sharaky, M. M., Ismail, S. H., & Shosha, N. N. H. (2022) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2022.952.960 · Cited by 4
Fanfarillo, F., Ferraguti, G., Lucarelli, M., Francati, S., Barbato, C., Minni, A., Ceccanti, M., Tarani, L., Petrella, C., & Fiore, M. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230403105438 · Cited by 4
Role of selenium in cell death
Gao, P.-N., Wang, C.-L., Xu, J., Liu, S., & Zhou, L. (2023) · journal of nutritional oncology · doi:10.1097/jn9.0000000000000009 · Cited by 5
Recent Advances in Therapeutic Application of DNA Damage Response Inhibitors against Cancer
Fernandes, S. G., Shah, P., & Khattar, E. (2021) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520621666210608105735 · Cited by 4
A Detailed Overview of ROS-Modulating Approaches in Cancer Treatment
Somu, P., Mohanty, S., & Paul, S. (2021) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_213-1 · Cited by 6
The Impact of Exercise on Redox Equilibrium in Cardiovascular Diseases
Sutkowy, P., Wróblewska, J., Wróblewski, M., Nuszkiewicz, J., Modrzejewska, M., & Woźniak, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11164833 · Cited by 4
“An oxidatively damaged DNA is also observed in people suffering from CVDs. 8-oxo-7,8-dihydro-2′-deoxyguanosine (8-oxodG) was widely assessed as a cellular [54] and urinary [55] marker of DNA oxidative damage.”
BackgroundInfluentialInterfacial regulation of glutathione redox reaction by nanobubbles
Tian, J., Zheng, J., Tian, Y., Hu, J., Wang, X., Zhang, L., & Zhang, Y. (2025) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2025.139163 · Cited by 3
Kim, T. H., Lee, C. R., Choi, K. M., Choi, S. W., Lee, S.-Y., Lee, A. R., Choi, J. Y., Moon, Y. M., Park, J., Choi, H., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-04020-7 · Cited by 4
“modulators of STAT3 phosphorylation [13, 14].”
Nanomaterial-based antibacterial strategies: Mechanisms, rational design, and future perspectives
Su, Y., Wang, N., Li, J., Han, Y., Fan, H., & He, Y. (2026) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2026.115478 · Cited by 3
Autophagy–Apoptosis Crosstalk in Cancer: Mechanisms, Signaling Pathways, and Therapeutic Targeting
Kakkar, D., Saxena, S., Dhawan, U., Dosi, N., Khanna, C., & Paul, S. (2026) · Cancers · doi:10.3390/cancers18101564 · Cited by 4
Cai, B.-Q., Chen, W.-M., Chen, M.-W., Chen, Y., & Tang, J. (2023) · Open Life Sciences · doi:10.1515/biol-2022-0790 · Cited by 3
“Oxidative stress [6] refers to increased intracellular reactive oxygen species (ROS) levels due to an imbalance between oxidants and antioxidants.”
BackgroundLi, H.-J., Wang, F., Zhang, X., Liang, B., Chen, Y., Chenxiang, Y., Liao, Q., Xue, F., Wang, D., & He, B. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.138700 · Cited by 3
Song, L., Zhao, F., Liu, Y., Guo, X., Wu, C., & Liu, J. (2021) · Current Therapeutic Research · doi:10.1016/j.curtheres.2021.100624 · Cited by 3
Nitrogen- and Sulfur-Containing Heterocycles as Dual Anti-oxidant and Anti-cancer Agents
Carradori, S., Guglielmi, P., Luisi, G., & Secci, D. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_180-1 · Cited by 3
Wu, X. Y., Li, F., Xie, W., Gong, B., Fu, B., Chen, W.-M., Zhou, L., & Luo, L. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1184841 · Cited by 3
Role of antioxidants in modulating anti-tumor T cell immune resposne
Oberholtzer, N. P., Mills, S. A., Mehta, S., Chakraborty, P., & Mehrotra, S. (2024) · Advances in cancer research · doi:10.1016/bs.acr.2024.05.003 · Cited by 3
Yin, X., Kan, D., Ruan, J., Wang, D., Chai, Y., Huang, S., Zhang, B., Wang, J., & Ji, X. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/9942462 · Cited by 3
“ROS are essential for the initiation, progression, and metastasis of cancer, and altered ROS levels in cancer cells are one of the reasons for recurrence/relapse [38].”
BackgroundGeneration and Application of Reactive Oxygen Radicals in Cancer Treatment
Patial, T., Sharma, N., Sharma, K., & Mishra, V. (2024) · ChemistrySelect · doi:10.1002/slct.202403648 · Cited by 2
Therapeutic innovations: targeting ROS production in AML with natural and synthetic compounds
Mohammed, M. H., Al-Aouadi, R. F. A., Uthirapathy, S., Sanghvi, G. V., M, R. M., Abdulamer, R. S., Prasad, G. V. S., Kundlas, M., Khamraev, F., & Ullah, M. I. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04054-6 · Cited by 2
“GPX reduces H ₂ O ₂ and lipid hydrop-eroxides using glutathione (GSH) as a substrate (Kirtonia et al. 2020).”
In Situ Ferroptosis with Global Dynamics Visualization for Glioblastoma Theranostics
Mungur, R., Han, P., Gu, J., Zhang, K., Zhang, X., Chatoo, M., Liu, Y., Shi, R., He, H., Lin, Y., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c02290 · Cited by 2
Admas, S., Teketelew, B. B., Alemu, N., Marelgn, L., & Gelaw, Y. (2026) · Therapeutic Advances in Hematology · doi:10.1177/20406207261419810 · Cited by 2
“15,78,79 However, in MM, DJ-1 inhibits ASK1 activation by preventing the dissociation of Trx1 from ASK1 and by increasing the transcription of Trx1, thus protecting myeloma cells from apoptosis (Figure 1(b)).”
Lagunas‐Rangel, F. A. (2026) · Journal of Xenobiotics · doi:10.3390/jox16020039 · Cited by 2
“Under physiological conditions, ROS are maintained at low and relatively stable levels, where they play essential roles in cell signaling and the regulation of cellular homeostasis [33].”
Yang, D., Li, Y., Ma, S.-Q., Zhang, Y., Huang, J., & He, L. (2023) · Molecules · doi:10.3390/molecules28073211 · Cited by 3
Dynamic hydrogen peroxide levels reveal a rate-dependent sensitivity in B-cell lymphoma signaling
Witmond, M., Keizer, E. M., Kiffen, B., Huck, W. T. S., & van Buggenum, J. A. G. L. (2024) · Scientific Reports · doi:10.1038/s41598-024-54871-7 · Cited by 2
Nanotechnology-based Approaches for Breast Cancer
Prabha, S., Panda, P. K., Singh, S., & Ahmed, B. (2024) · Current Cancer Therapy Reviews · doi:10.2174/0115733947282469240212075845 · Cited by 2
Expression of amine oxidase-related proteins in breast phyllodes tumor.
Kim, H. M., & Koo, J. S. (2025) · PubMed · doi:10.14670/hh-18-773 · Cited by 2
Chen, B., Tan, H. S., Li, C., Li, L., Zhang, Z., & Li, Z. (2024) · Biotechnology Letters · doi:10.1007/s10529-024-03513-z · Cited by 2
“This leads to an increased consumption of ATP in order to maintain redox balance and facilitate cell repair (Kirtonia et al. 2020).”
Anwar, K., Thaller, G. E., & Saeed‐Zidane, M. (2024) · Cells · doi:10.3390/cells13191601 · Cited by 2
“NF-E2-related factor 2 ( NRF2 ) is a transcription factor protein-coding gene that is considered a key master transcription regulator of numerous antioxidant enzymes [22].”
BackgroundSupramolecular nanomedicine in the intelligent cancer therapy: recent advances and future
Li, S., Wang, Y., Li, C., Zhou, B., Zeng, X., & Zhu, H. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1490139 · Cited by 2
Targeting Reactive Oxygen Species Homeostasis and Metabolism in Cancer Stem Cells
Grieve, S., & Biswas, D. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_150 · Cited by 2
EFFECT OF RADIATION ON AGING PROCESSES AND TELOMERE LENGTH
Dondoladze, K., Nikolaishvili, M., Museliani, T., & Jikia, G. (2022) · Проблеми радіаційної медицини та радіобіології = Problems of Radiation Medicine and Radiobiology · doi:10.33145/2304-8336-2022-27-107-119 · Cited by 3
Arai, H., Millstein, J., Yang, Y., Stintzing, S., Wang, J., Battaglin, F., Kawanishi, N. K., Jayachandran, P., Soni, S., Zhang, W., et al. (2022) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2022.05.005 · Cited by 2
Vallés‐Martí, A., Böttger, F., Yau, E., Tejjani, K., Meijs, L. A. M., Sharma, S., Mumtaz, M., Large, T. Y. S. L., Erozenci, L. A., Dekker, D., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.19.572293 · Cited by 2
Sun, L., Wang, X., Ma, B., Zuo, C., Xia, Y., Guo, Y., & Han, M. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105429 · Cited by 2
Sabra, R. T., Bekhit, A. A., Sabra, N. T., El-Moeze, N. A. A., & Fathy, M. (2024) · Stresses · doi:10.3390/stresses4040053 · Cited by 1
Jhetam, Z., Martins-Furness, C., Slabber, C., Munro, O. Q., Nel, M., & Harmse, L. (2024) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2024.112815 · Cited by 1
Banerjee, S., Das, A., Bose, S., Banerjee, S., Bishayee, A., & Bishayee, A. (2025) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2025.101220 · Cited by 1
“The highly reactive species further act as signaling molecules to propel oncogenic pathways by triggering fibroblast proliferation and hyperplasia of regional epithelial cells, thus causing perpetual deformation of the tissue architecture [9].”
D’Angelo, M., Medugno, A., Cuomo, M., Ragosta, M. C., Russo, A., Mazzarotti, G., Napolitano, G. M., Iannuzzi, C. A., Errichiello, F., Frusciante, L., et al. (2025) · Antioxidants · doi:10.3390/antiox14091096 · Cited by 1
Zhang, C., Liu, S., Wan, J., Zhang, W., Zhong, L., & Lü, X. (2025) · Biomedical Optics Express · doi:10.1364/boe.560107 · Cited by 1
Wang, Z., Lyu, Z., Palmen, R., Bao, Q., Popp, F., Dong, Q., Bruns, C. J., & Zhao, Y. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-02948-9 · Cited by 1
“The tumor suppressor functions of PINK1 and PRKN are primarily due to selective clearance of depolarized mitochondria through mito-phagy, thereby preventing Warburg metabolism and excess ROS, which is essential for tumorigenesis [58, 59].”
Wang, H., Luo, C. L., Chen, W. K., Wang, Y., Sun, S., Deng, J., Xu, W., & Li, Z. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.151668 · Cited by 1
Functional reprogramming of bone marrow neutrophils in tumor-driven emergency granulopoiesis
Chandel, R., & Shrivastava, A. (2026) · Immunology Letters · doi:10.1016/j.imlet.2026.107210 · Cited by 1
Cellular senescence and aging: molecular mechanisms and convergent pathways
Piritore, F. C., Braggio, M., Minoia, A., Bolognin, S., Cominacini, M., Trabetti, E., Bombieri, C., Romanelli, M. G., Carbonare, L. D., & Valenti, M. T. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06317-8 · Cited by 1
“This oxidation causes ASK-1 to dis - sociate and become active, subsequently activating JNK and p38 [110]. p38 is known to activate p53, leading cells to a senescent state [111].”
Ferroptosis in T cells: mechanisms, biology and translational opportunities
宋靜淑, Wu, Q., Green, D. R., Wang, F., & Min, J. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01337-8 · Cited by 1
ROS in Apoptosis of Cancer Cells
Bayır, A. G. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_41-1 · Cited by 1
The Stress, Healing, and Resilience Nursing Model of Whole Person Care
Grossman, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-06101-1_2 · Cited by 1
Sönmez, F., GÜR, T., & Şahin, Z. (2023) · Balıkesir Üniversitesi Fen Bilimleri Enstitüsü Dergisi · doi:10.25092/baunfbed.1119869 · Cited by 1
Role of Hypoxia and Reactive Oxygen Species in Cancer Biology
Hemagirri, M., Hong, H. J., Huda, H., Kavilasha, V., Chen, Y., Kanwar, J. R., & Sasidharan, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-0313-9_3 · Cited by 1
Cao, Y., Fu, A., & Liu, C. (2024) · Advanced Biology · doi:10.1002/adbi.202300659 · Cited by 1
Bioactivities of Cholistani harmal (Peganum harmala) with exploration of bioactive phytochemicals
Kamran, M. Z., Din, M. U., Sahu, M. R., Ahmad, J., Bilal, B., Bilal, M., Jamil, N., Yasir, M., & Kanwal, Q. (2024) · International Journal of Chemical and Biochemical Sciences · doi:10.62877/12-ijcbs-24-25-19-12 · Cited by 1
Oxyhydrogen Gas: A Promising Therapeutic Approach for Lung, Breast and Colorectal Cancer
Russell, G., & Nenov, A. (2024) · Oxygen · doi:10.3390/oxygen4030020 · Cited by 1
“For example, ROS generated during normal cellular metabolism can directly damage DNA by causing mutations and lesions, with oxygen radicals adhering to nucleotide bases, an action that can lead to genetic alterations which may initiate carcinogenesis [32].”
BackgroundWhy Ashwagandha for Healthy Ageing? Evidence from Cultured Human Cells
Wadhwa, R., Garg, S., Khurana, M., & Kaul, S. C. (2021) · Healthy ageing and longevity · doi:10.1007/978-3-030-83017-5_28 · Cited by 1
Targeting Reactive Oxygen Species Homeostasis and Metabolism in Cancer Stem Cells
Grieve, S., & Biswas, D. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_150-1 · Cited by 1
ROS-Mediated Inflammatory Response in Cancer
Muralidar, S., Gopal, G., & Ambi, S. V. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_181 · Cited by 1
Supportive Care and End of Life
Grossman, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-06101-1_18 · Cited by 1
A Detailed Overview of ROS-Modulating Approaches in Cancer Treatment
Somu, P., Mohanty, S., & Paul, S. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_213 · Cited by 1
α-Lipoic Acid Induces Intrinsic Apoptosis in Human Oral Squamous Carcinoma CellsPreprint
Revathi Duraisamy, M. D. S., Ezhilarasan, D., & Perumal, E. (2021) · Research Square · doi:10.21203/rs.3.rs-583798/v1 · Cited by 1
Basal Gp78-dependent mitophagy promotes mitochondrial health and limits mitochondrial ROSPreprint
Nabi, I. R., Alan, P., Vandevoorde, K. R., Joshi, B., Cardoen, B., Gao, G., Mohammadzadeh, Y., & Hamarneh, G. (2022) · Research Square · doi:10.21203/rs.3.rs-1559637/v1 · Cited by 1
Hu, B., Li, J., Gong, D., Dai, Y., Wan, L., & Xu, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1501143/v1 · Cited by 1
Vallés‐Martí, A., Böttger, F., Yau, E., Tejjani, K., Meijs, L. A. M., Sharma, S., Mumtaz, M., Large, T. Y. S. L., Erozenci, L. A., Dekker, D., et al. (2024) · eLife · doi:10.7554/elife.94988.1 · Cited by 1
Jin, F., Wang, R., Zhu, Y., Chen, J., Cao, W., Wang, Y., Wu, Y., Song, X., Huang, Y., Dong, J., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173497
ROS in Apoptosis of Cancer Cells
Bayır, A. G. (2021)
ROS-Mediated Inflammatory Response in Cancer
Muralidar, S., Gopal, G., & Ambi, S. V. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_181-1
ROS Modulation by Iron Chelators and Lipids: A Developing Anticancer Strategy
Kakhlon, O. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_129-1
Pour, P. M., Yegdaneh, A., Aghaei, M., Kazemi, F., & Ghanadian, M. (2021) · Nutrition and Cancer · doi:10.1080/01635581.2021.2007961
“Therefore, the oxidative stress response modulation may have a potential role to eradicate cancerous cells followed by FDA-approved radiotherapies, chemotherapies, plus immunotherapies (40).”
BackgroundChlorogenic Acid Alleviated Liver Dysfunction Through Activating PINK1/Parkin Dependent MitophagyPreprint
Hu, B., Li, J., Gong, D., Dai, Y., Wan, L., & Xu, S. (2021) · Research Square · doi:10.21203/rs.3.rs-976056/v1
ROS in Apoptosis of Cancer Cells
Bayır, A. G. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_41
Li, S., Zhang, W., Lan, X., Tan, L., Chen, X., Lv, K., Huang, Z., Gou, L., Wan, J., & Meng, X. (2022) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2022.3259
ROS Modulation by Iron Chelators and Lipids: A Developing Anticancer Strategy
Kakhlon, O. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_129
Role of Indian Ginseng Withaferin A in ROS-Induced Cancer Chemoprevention and Cancer Therapy
Mounica, P. K., Devabattula, G., & Godugu, C. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-1247-3_22-1
Effects of Water-Soluble Propolis on tert-Butyl Hydroperoxide-Induced Acute Oxidative Stress in Mice
Kim, H.-R., Kim, M. J., Noh, E., Hur, Y. K., & Kim, S. (2022) · Food Supplements and Biomaterials for Health · doi:10.52361/fsbh.2022.2.e6
Wen, C., Ruan, Q., Li, Z., Zhou, X., Xuezhi, Y., Xu, P., Akuetteh, P. D. P., Xu, Z., & Deng, J. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3924148
Zhu, Y., Lei, C., Jiang, Q., Yu, Q., & Qiu, L. (2022) · Research Square · doi:10.21203/rs.3.rs-1620609/v1
Pathophysiology of Diabetes‐Induced Complications
Dahiya, R., Buttar, H. S., & Gupta, S. (2022) · Wiley eBooks · doi:10.1002/9781119746843.ch30
Sarmento‐Ribeiro, A. B., Botelho, M. F., Gonçalves, A. C., Melo, J. B., Laranjo, M., Alves, R., Jorge, J., Ribeiro, I. P., Pires, S., Abrantes, A. M., et al. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823761-8.00026-4
Role of Indian Ginseng Withaferin A in ROS-Induced Cancer Chemoprevention and Cancer Therapy
Mounica, P. K., Devabattula, G., & Godugu, C. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_22
Grossman, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-06101-1_3
Biological Processes of Resilience
Grossman, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-06101-1_4
Grossman, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-06101-1_6
Grossman, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-06101-1_7
Grossman, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-06101-1_15
Metadata
- Authors
- Kirtonia, A., Sethi, G., & Garg, M.
- Affiliations
- Amity University (IN)
- National University of Singapore (SG)
- Corresponding author
- Sethi, Gautam
- Garg, Manoj
- Venue
- Cellular and Molecular Life Sciences
- Published
- 2020-05-01
- Volume
- 77
- Issue
- 22
- Pages
- 4459-4483
- ISSN
- 1420-682X (ISSN-L)
- 1420-9071
- PMC
- PMC11105050
- OpenAlex
- W3022746266
- Cited by
- 452
- References
- 257
- Citations by year
- 2026: 33 · 2025: 45 · 2024: 90 · 2023: 72 · 2022: 106 · 2021: 80 · 2020: 26
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Department of Biotechnology , Ministry of Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- reactive oxygen species, carcinogenesis, redox homeostasis, oxidative stress, metastasis, angiogenesis, oncogenic signaling, DNA mutations, tumor microenvironment, cancer stem cells, drug resistance, anticancer agents, immunotherapy, radiotherapy, chemotherapy
- MeSH terms
- Animals, Humans, Neoplasm Recurrence, Local, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Oxidative Stress, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review